TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis-like transcriptomes

Mika Murai-Yamamura; Sandra Garcet; Kazuhiko Yamamura; Juana Gonzalez; Shunsuke Miura; Xuan Li; Hong Hur; Emma Guttman-Yassky; James G. Krueger

doi:10.1111/all.15035

T_H2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis-like transcriptomes

Mika Murai-Yamamura, Sandra Garcet, Kazuhiko Yamamura, Juana Gonzalez, Shunsuke Miura, Xuan Li, Hong Hur, Emma Guttman-Yassky, James G. Krueger

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	3534-3537
Number of pages	4
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	76
Issue number	11
DOIs	https://doi.org/10.1111/all.15035
State	Published - Nov 2021

Keywords

atopic dermatitis
dermatology
infections
inflammation
innate immunity
keratinocytes

Access to Document

10.1111/all.15035

Cite this

@article{b88eb4a4d3b84130879821df5c279945,

title = "TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis-like transcriptomes",

keywords = "atopic dermatitis, dermatology, infections, inflammation, innate immunity, keratinocytes",

author = "Mika Murai-Yamamura and Sandra Garcet and Kazuhiko Yamamura and Juana Gonzalez and Shunsuke Miura and Xuan Li and Hong Hur and Emma Guttman-Yassky and Krueger, {James G.}",

note = "Funding Information: KY was supported by Japan Society for the Promotion of Science (JSPS) overseas research fellowships from 2020 to 2022. SM was supported by a fellowship from the Uehara Memorial Foundation (award number: 201830050). EGY has received research funds (grants paid to the institution) from Abbvie, Almirall, Amgen, AnaptysBio, Asana Biosciences, AstraZeneca, Boerhinger‐Ingelhiem, Celgene, Dermavant, DS Biopharma, Eli Lilly, Galderma, Glenmark/Ichnos Sciences, Innovaderm, Janssen, Kiniksa, Kyowa Kirin, Leo Pharma, Novan, Novartis, Pfizer, Ralexar, Regeneron Pharmaceuticals, Inc., Sienna Biopharma, UCB, and Union Therapeutics/Antibiotx; and is a consultant for Abbvie, Aditum Bio, Almirall, Alpine, Amgen, Arena, Asana Biosciences, AstraZeneca, Bluefin Biomedicine, Boerhinger‐Ingelhiem, Boston Pharmaceuticals, Botanix, Bristol‐Meyers Squibb, Cara Therapeutics, Celgene, Clinical Outcome Solutions, DBV, Dermavant, Dermira, Douglas Pharmaceutical, DS Biopharma, Eli Lilly, EMD Serono, Evelo Bioscience, Evidera, FIDE, Galderma, GSK, Haus Bioceuticals, Ichnos Sciences, Incyte, Kyowa Kirin, Larrk Bio, Leo Pharma, Medicxi, Medscape, Neuralstem, Noble Insights, Novan, Novartis, Okava Pharmaceuticals, Pandion Therapeutics, Pfizer, Principia Biopharma, RAPT Therapeutics, Realm, Regeneron Pharmaceuticals, Inc., Sanofi, SATO Pharmaceutical, Sienna Biopharma, Seanegy Dermatology, Seelos Therapeutics, Serpin Pharma, Siolta Therapeutics, Sonoma Biotherapeutics, Sun Pharma, Target PharmaSolutions, Union Therapeutics, Vanda Pharmaceuticals, Ventyx Biosciences, Vimalan, and Concert. JGK has received research funds (grants paid to institution) from Novartis, Pfizer, Amgen, Lilly, Boehringer, Innovaderm, BMS, Janssen, Abbvie, Paraxel, Leo Pharma, Vitae, Akros, Regeneron, Allergan, Novan, Biogen MA, Sienna, UCB, Celgene, Botanix, Incyte, Avillion, and Exicure, and personal fees from Novartis, Pfizer, Amgen, Lilly, Boehringer, BiogenIdec, Abbvie, Leo Pharma, Escalier, Valeant, Aurigne, Allergan, Asana, UCB, Sienna, Celgene, Nimbus, Menlo, Aristea, Sanofi, Sun Pharma, Almirall, Arena, BMS, Ventyx, Aclaris, and Galapagos. ",

year = "2021",

month = nov,

doi = "10.1111/all.15035",

language = "English",

volume = "76",

pages = "3534--3537",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11",

}

TY - JOUR

T1 - TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis-like transcriptomes

AU - Murai-Yamamura, Mika

AU - Garcet, Sandra

AU - Yamamura, Kazuhiko

AU - Gonzalez, Juana

AU - Miura, Shunsuke

AU - Li, Xuan

AU - Hur, Hong

AU - Guttman-Yassky, Emma

AU - Krueger, James G.

N1 - Funding Information: KY was supported by Japan Society for the Promotion of Science (JSPS) overseas research fellowships from 2020 to 2022. SM was supported by a fellowship from the Uehara Memorial Foundation (award number: 201830050). EGY has received research funds (grants paid to the institution) from Abbvie, Almirall, Amgen, AnaptysBio, Asana Biosciences, AstraZeneca, Boerhinger‐Ingelhiem, Celgene, Dermavant, DS Biopharma, Eli Lilly, Galderma, Glenmark/Ichnos Sciences, Innovaderm, Janssen, Kiniksa, Kyowa Kirin, Leo Pharma, Novan, Novartis, Pfizer, Ralexar, Regeneron Pharmaceuticals, Inc., Sienna Biopharma, UCB, and Union Therapeutics/Antibiotx; and is a consultant for Abbvie, Aditum Bio, Almirall, Alpine, Amgen, Arena, Asana Biosciences, AstraZeneca, Bluefin Biomedicine, Boerhinger‐Ingelhiem, Boston Pharmaceuticals, Botanix, Bristol‐Meyers Squibb, Cara Therapeutics, Celgene, Clinical Outcome Solutions, DBV, Dermavant, Dermira, Douglas Pharmaceutical, DS Biopharma, Eli Lilly, EMD Serono, Evelo Bioscience, Evidera, FIDE, Galderma, GSK, Haus Bioceuticals, Ichnos Sciences, Incyte, Kyowa Kirin, Larrk Bio, Leo Pharma, Medicxi, Medscape, Neuralstem, Noble Insights, Novan, Novartis, Okava Pharmaceuticals, Pandion Therapeutics, Pfizer, Principia Biopharma, RAPT Therapeutics, Realm, Regeneron Pharmaceuticals, Inc., Sanofi, SATO Pharmaceutical, Sienna Biopharma, Seanegy Dermatology, Seelos Therapeutics, Serpin Pharma, Siolta Therapeutics, Sonoma Biotherapeutics, Sun Pharma, Target PharmaSolutions, Union Therapeutics, Vanda Pharmaceuticals, Ventyx Biosciences, Vimalan, and Concert. JGK has received research funds (grants paid to institution) from Novartis, Pfizer, Amgen, Lilly, Boehringer, Innovaderm, BMS, Janssen, Abbvie, Paraxel, Leo Pharma, Vitae, Akros, Regeneron, Allergan, Novan, Biogen MA, Sienna, UCB, Celgene, Botanix, Incyte, Avillion, and Exicure, and personal fees from Novartis, Pfizer, Amgen, Lilly, Boehringer, BiogenIdec, Abbvie, Leo Pharma, Escalier, Valeant, Aurigne, Allergan, Asana, UCB, Sienna, Celgene, Nimbus, Menlo, Aristea, Sanofi, Sun Pharma, Almirall, Arena, BMS, Ventyx, Aclaris, and Galapagos.

PY - 2021/11

Y1 - 2021/11

KW - atopic dermatitis

KW - dermatology

KW - infections

KW - inflammation

KW - innate immunity

KW - keratinocytes

UR - http://www.scopus.com/inward/record.url?scp=85113148878&partnerID=8YFLogxK

U2 - 10.1111/all.15035

DO - 10.1111/all.15035

M3 - Letter

C2 - 34358351

AN - SCOPUS:85113148878

SN - 0105-4538

VL - 76

SP - 3534

EP - 3537

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 11

ER -